HK1220766A1 - 識別共刺激阻斷抗排斥反應的高危患者的方法 - Google Patents

識別共刺激阻斷抗排斥反應的高危患者的方法

Info

Publication number
HK1220766A1
HK1220766A1 HK16108807.8A HK16108807A HK1220766A1 HK 1220766 A1 HK1220766 A1 HK 1220766A1 HK 16108807 A HK16108807 A HK 16108807A HK 1220766 A1 HK1220766 A1 HK 1220766A1
Authority
HK
Hong Kong
Prior art keywords
risk
methods
identifying patients
costimulation blockade
resistant rejection
Prior art date
Application number
HK16108807.8A
Other languages
English (en)
Inventor
D Kirk Allan
Rae Espinosa Jaclyn
M Townsend Robert
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HK1220766A1 publication Critical patent/HK1220766A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Prostheses (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108807.8A 2013-03-28 2016-07-22 識別共刺激阻斷抗排斥反應的高危患者的方法 HK1220766A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361806206P 2013-03-28 2013-03-28
PCT/US2014/031945 WO2014160822A1 (en) 2013-03-28 2014-03-27 Methods for identifying patients at risk for costimulation blockade resistant rejection

Publications (1)

Publication Number Publication Date
HK1220766A1 true HK1220766A1 (zh) 2017-05-12

Family

ID=50686197

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108807.8A HK1220766A1 (zh) 2013-03-28 2016-07-22 識別共刺激阻斷抗排斥反應的高危患者的方法

Country Status (12)

Country Link
US (4) US20160153990A1 (zh)
EP (1) EP2981825A1 (zh)
JP (1) JP2016515706A (zh)
KR (1) KR20150137087A (zh)
AU (1) AU2014241195A1 (zh)
BR (1) BR112015024516A2 (zh)
CA (1) CA2908272A1 (zh)
EA (1) EA201591883A1 (zh)
HK (1) HK1220766A1 (zh)
MX (1) MX2015013507A (zh)
SG (1) SG11201506919XA (zh)
WO (1) WO2014160822A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201418896D0 (en) * 2014-10-23 2014-12-10 Isis Innovation Biomarker and therapy intervention for malignancy risk patients
JP6749593B2 (ja) * 2017-03-10 2020-09-02 国立大学法人横浜国立大学 モノクローナル抗体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69227112D1 (de) 1991-07-16 1998-10-29 Transmed Biotech Inc Verfahren und zusammensetzungen für die gleichzeitige analyse einer vielzahl von analyten
ATE390931T1 (de) * 2001-05-23 2008-04-15 Bristol Myers Squibb Co Verfahren zum schützen eines allogenen inseltransplantats mit löslichen ctla4- mutationsmolekülen
LT1868635T (lt) * 2005-04-06 2017-07-10 Bristol-Myers Squibb Company Imuninių sutrikimų, susijusių su transplantato persodinimu, gydymo būdas tirpiomis mutantinėmis ctla4 molekulėmis

Also Published As

Publication number Publication date
EA201591883A1 (ru) 2016-02-29
US20170328903A1 (en) 2017-11-16
EP2981825A1 (en) 2016-02-10
AU2014241195A1 (en) 2015-11-12
US20220334112A1 (en) 2022-10-20
US20160153990A1 (en) 2016-06-02
CA2908272A1 (en) 2014-10-02
MX2015013507A (es) 2016-01-14
KR20150137087A (ko) 2015-12-08
US11385228B2 (en) 2022-07-12
WO2014160822A1 (en) 2014-10-02
JP2016515706A (ja) 2016-05-30
BR112015024516A2 (pt) 2017-10-24
SG11201506919XA (en) 2015-10-29
US10488413B2 (en) 2019-11-26
US20200072838A1 (en) 2020-03-05

Similar Documents

Publication Publication Date Title
IL268987B (en) Glaucoma treatment system
IL278018A (en) Methods for the treatment or prevention of ophthalmological conditions
EP2967521A4 (en) SENSITIVE SURGICAL SYSTEM
EP2740430A4 (en) MEDICAL SYSTEM
EP2852349A4 (en) PROCESS PLANNING SYSTEM
PL2764881T3 (pl) System leczenia medycznego
EP2872028A4 (en) MEDICAL SYSTEM
HUS2000037I1 (hu) Triazinok Protozoa okozta betegségek kezelésére
EP3016060A4 (en) SYSTEM FOR ANALYZING MEDICAL CARE PROCESSES
HK1212772A1 (zh) 血液凝結計和方法
HUE039650T2 (hu) Rendszer gyógykezeléshez
EP2974730A4 (en) MEDICINES FOR RESPIRATORY DISEASES
GB2519400B (en) Apparatus for blood concentration
IL245541A0 (en) New methods for the treatment of neurodegenerative diseases
HK1211455A1 (zh) 神經阻滯導管
HK1218581A1 (zh) 用於快速存取生理測量歷史的系統和方法
GB201309375D0 (en) Medical methods and compounds for medical use
HK1220766A1 (zh) 識別共刺激阻斷抗排斥反應的高危患者的方法
EP2947462A4 (en) SAMPLE PROCESSING SYSTEM
ZA201601248B (en) Wheelchair
EP2740398A4 (en) MEDICAL SYSTEM
GB201307289D0 (en) Cover for medical probe
EP2967346A4 (en) IMPROVED PATIENT MONITORING SYSTEM
SG2013077433A (en) Patient monitoring system
AU349126S (en) Wheelchair